Sarowar Golam

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population

Marjan Kerkhof, Trung N. Tran, Joan B. Soriano et al. · Thorax · 2017 · 161 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +14

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

Jaco Voorham, Xiao Xu, David Price et al. · Allergy · 2018 · 119 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +12

The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

J. Mark FitzGerald, Sofie Arnetorp, Caitlin Smare et al. · Respiratory Medicine · 2020 · 22 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15

The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

Sarowar Golam, Christer Janson, Richard Beasley et al. · Respiratory Medicine · 2022 · 20 citations · Full text

Medicine, Internal Medicine, Primary Care +16

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada

Mohsen Sadatsafavi, J. Mark FitzGerald, Paul M. O’Byrne et al. · Allergy Asthma and Clinical Immunology · 2021 · 17 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17